Algomedica sp. z o.o.

Computer programming activities

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2020-02-24
Share capital
50,000.00 PLN
Activity description

Algomedica is an innovative startup that provides tools for doctors and patients, including the creation of individual therapy plans that can be shared via a mobile app, email, or PDF. The company offers ready-to-use algorithms for HIV and HCV drug recommendations and allows users to develop their own algorithms for other diseases. Additionally, Algomedica utilizes AI for data analysis and to enhance therapy recommendations based on patient feedback.

Registered address
ul. Ks. Piotra Skargi 15/8, 71-422 Szczecin, Poland
Email
Phone
Social media

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2025 – the filing deadline has passed. 4 of 5 financial statements were filed late (the longest delay 304 days for 2021).

  • 2025not filed
  • 202422/08/2025
  • 202308/12/2024
  • 202227/10/2023
  • 202115/05/2023
  • 202011/05/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2024.

Industry · Computer programming activities7,494 / 11,174
Top 67%
Sector · Information and communication13,850 / 21,342
Top 65%
Voivodeship · Zachodniopomorskie11,590 / 17,082
Top 68%
Country · Poland337,408 / 496,512
Top 68%

Results vs industry

Revenue
This companyUSD 48.25kMedianUSD 120.54kAverageUSD 1.77m
Net profit
This companyUSD -43.56kMedianUSD 2.92kAverageUSD 23.81k
Operating costs
This companyUSD 71.77kMedianUSD 112.29kAverageUSD 1.69m
Assets
This companyUSD 74.04kMedianUSD 79.64kAverageUSD 1.14m

Offer

Websites

  • algomedica.techAlgomedica – Algorithms in medicine
    WordPress 7.1Cloudflare

Authorized Representatives

Marcin Przemysław Horecki age 49 – President of the Management Board

Manner of representation

Each member of the management board is authorized to make declarations on behalf of the company independently.

Ownership

OwnerSharesShare valueStake
95$12,830.9095%
Others
5$675.315%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2020-09-10.

  • mBank
    58 1140 2004 0000 3202 7985 6443

Debt

No entries in the National Debtors Register (KRZ).

Public aid

5 public aid cases recorded, with a total value of $207,486.

PurposeGross amount
De minimis aid (in accordance with Commission Regulation 2023/2831)
$50,163
Aid for research and development projects: industrial research
$96,735
Aid for research and development projects: experimental development
$57,550

European Funds

ProjectEU co-financing
Preparation of content for the Neuro-Asystent application and conducting application tests with post-stroke patients in clinical settings
$50,163
Creating innovative applications to support healthcare workers and the therapeutic process
$277.2K

Competitors

Name
Diagu sp. z o.o.
Polmedi Group sp. z o.o.
AMMA sp. z o.o.
MAKE Me Diet sp. z o.o.
Revolet sp. z o.o.
Terapia Plus sp. z o.o.
Pharmdiver sp. z o.o.
Apteczka Pacjenta sp. z o.o.
PRP Analytics sp. z o.o.
Blockbox sp. z o.o.

Change history

DateEvent
2021-09-22Address change
2021-05-06Share capital increase
2021-05-06PKD change
2020-02-24Entered in the register

FAQ

Last updated: 2026-04-18